Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp

J Nat Prod. 2010 Sep 24;73(9):1529-37. doi: 10.1021/np100352e.

Abstract

Material collected from a parkway in the city of Chicago afforded the isolation of a Nostoc species (UIC 10022A). The extract of this strain displayed significant inhibition of the 20S proteasome as well as antiproliferative activity against HT29, MCF7, NCI-H460, and SF268 cancer cell lines. A standardized dereplication protocol allowed for the rapid identification of three known (11-13) and nine new (1-9) chlorinated cylindrocyclophanes from less than 100 mg of organic extract. Scale-up isolation of 1-9 and 11-13 from a larger extract was guided by LC-UV-MS data. In addition, KBr enrichment of the culture media afforded the isolation of a brominated cylindrocyclophane (10). Biological evaluation of 1-5, 9, and 10-13 revealed a large range of activity against the 20S proteasome and allowed the determination of preliminary structure-activity relationships of the cylindrocyclophane pharmacophore.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification*
  • Antineoplastic Agents / pharmacology
  • Chicago
  • Drug Screening Assays, Antitumor
  • HT29 Cells
  • Humans
  • Molecular Structure
  • Nostoc / chemistry*
  • Nuclear Magnetic Resonance, Biomolecular
  • Polycyclic Aromatic Hydrocarbons / chemistry
  • Polycyclic Aromatic Hydrocarbons / isolation & purification*
  • Polycyclic Aromatic Hydrocarbons / pharmacology*
  • Proteasome Inhibitors*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Polycyclic Aromatic Hydrocarbons
  • Proteasome Inhibitors
  • cylindrocyclophane A